Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Analgesics, Opioid: later-stage trial registry
2 of 4 indexed Analgesics, Opioid trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Analgesics, Opioid: 4 US clinical trials tracked, 2 recruiting.
Analgesics, Opioid is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Loyola University, running 1 of these trials.
Enrollment posture brief
Registry condition analgesics-opioid
OPEN 2 | RECR 50% | LATE 3 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Analgesics, Opioid lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Analgesics, Opioid on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Analgesics, Opioid is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Optimizing Pain Treatment in Children On Mechanical Ventilation
Weill Medical College of Cornell University
NCT06994442
IPACK on Early Pain Scores After ACL Reconstruction
Loyola University
NCT05985629
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
University of North Carolina, Chapel Hill
NCT03809507
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
University of California, Los Angeles
NCT03294109
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Analgesics, Opioid records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Analgesics, Opioid trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Analgesics, Opioid page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Analgesics, Opioid trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Loyola University sponsors the most Analgesics, Opioid trials on record, review their full trial history before evaluating a specific study. See Loyola University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Analgesics, Opioid condition card totals 4 registered trials; most-linked intervention Abdominal wall block with liposomal bupivicaine; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.